Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 22 Oct 2024 07:30 CEST |
WENDEL | Wendel announces a transformational transaction in line with its strategic roadmap | 30202000 Diversified Financial Services | Mergers, Acquiqitions, Transferts |
| 22 Oct 2024 07:30 CEST |
EVERFUEL | MINIMUM ACCEPTANCE CONDITION SATISFIED FOR THE UNREGULATED RECOMMENDED VOLUNTARY CASH OFFER OF NOK 13 PER SHARE TO THE SHAREHOLDERS OF EVERFUEL A/S | 60102010 Alternative Fuels | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Oct 2024 07:30 CEST |
- | Un péage poids lourds sans barrière mis en service en Espagne | - | Other subject |
| 22 Oct 2024 07:30 CEST |
EXOSENS | Exosens signe un accord en vue d’acquérir NVLS (Night Vision Laser Spain), un spécialiste des équipements de vision nocturne | 50202025 Electronic Equipment: Gauges and Meters | Mergers, Acquiqitions, Transferts |
| 22 Oct 2024 07:30 CEST |
SpareBank 1 Sogn og Fjordane | SpareBank 1 Gruppen - resultat 3. kvartal 2024 og resultateffekt for SpareBank 1 Sogn og Fjordane | - | Annen informasjonspliktig regulatorisk informasjon |
| 22 Oct 2024 07:30 CEST |
SpareBank 1 Sør-Norge ASA | SpareBank 1 Gruppen – Q3 2024 Results | 30101010 Banks | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Oct 2024 07:30 CEST |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |
| 22 Oct 2024 07:30 CEST |
Eika Forsikring AS 15/45 FRN STEP C SUB | Tredje kvartal 2024 | - | Annen informasjonspliktig regulatorisk informasjon |
| 22 Oct 2024 07:30 CEST |
SpareBank 1 SMN | SpareBank 1 Gruppen – Q3 2024 Results | 30101010 Banks | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Oct 2024 07:30 CEST |
SPAREBANK 1 HELGELAND | SpareBank 1 Gruppen – Q3 2024 Results | 30101010 Banks | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Oct 2024 07:30 CEST |
SpareBank 1 Østlandet | SpareBank 1 Østlandet (SPOL): SpareBank 1 Gruppen – resultat per. 3 kvartal og i 3. kvartal 2024 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
| 22 Oct 2024 07:30 CEST |
SpareBank 1 Nordmøre | SNOR: SpareBank 1 Gruppen – resultat per. 3 kvartal og i 3. kvartal 2024 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
| 22 Oct 2024 07:30 CEST |
SpareBank 1 Østfold Akershus | SpareBank 1 Gruppen – resultat per. 3 kvartal og i 3. kvartal 2024 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
| 22 Oct 2024 07:30 CEST |
CROSSJECT | Crossject reports strong manufacturing progress with its epilepsy rescue therapy ZEPIZURE® ahead of filing U.S. Emergency Use Authorization | 20102010 Medical Equipment | - |
| 22 Oct 2024 07:30 CEST |
BW ENERGY LIMITED | BW Energy: Q3 2024 trading update | 60101010 Oil: Crude Producers | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Oct 2024 07:30 CEST |
SpareBank 1 Nord-Norge | SpareBank 1 Gruppen – resultat per. 3 kvartal og i 3. kvartal 2024 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
| 22 Oct 2024 07:30 CEST |
EXOSENS | Exosens announces agreement to acquire NVLS (Night Vision Laser Spain), specialist in night vision equipment | 50202025 Electronic Equipment: Gauges and Meters | Mergers, Acquiqitions, Transferts |
| 22 Oct 2024 07:30 CEST |
Eika Gruppen AS | Fremtind Holding konsern - Resultat 3. kvartal 2024 og hittil i år | - | Annen informasjonspliktig regulatorisk informasjon |
| 22 Oct 2024 07:30 CEST |
SpareBank 1 Sør-Norge ASA | SpareBank 1 Gruppen – resultat per. 3 kvartal og i 3. kvartal 2024 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
| 22 Oct 2024 07:30 CEST |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
| 22 Oct 2024 07:30 CEST |
SpareBank 1 Østlandet | SpareBank 1 Østlandet (SPOL): SpareBank 1 Gruppen – 3Q 2024 Results | 30101010 Banks | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Oct 2024 07:30 CEST |
SpareBank 1 SMN | SpareBank 1 Gruppen – resultat per. 3 kvartal og i 3. kvartal 2024 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
| 22 Oct 2024 07:30 CEST |
SPAREBANK 1 HELGELAND | SpareBank 1 Gruppen – resultat per. 3 kvartal og i 3. kvartal 2024 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
| 22 Oct 2024 07:30 CEST |
SpareBank 1 Ringerike Hadeland | SpareBank 1 Ringerike Hadeland: SpareBank 1 Gruppen – resultat per. 3 kvartal og i 3. kvartal 2024 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
| 22 Oct 2024 07:30 CEST |
CROSSJECT | Crossject annonce des progrès majeurs dans la fabrication de son traitement d’urgence ZEPIZURE®, pour la prise en charge des crises d’épilepsie, à l’approche du dépôt d’une demande d’autorisation d’utilisation d’urgence aux États-Unis. | 20102010 Medical Equipment | - |
| 22 Oct 2024 07:30 CEST |
SpareBank 1 Nord-Norge | SpareBank 1 Gruppen – Q3 2024 Results | 30101010 Banks | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Oct 2024 07:15 CEST |
EUROFINS SCIENTIFIC | Eurofins Announces Results of Cash Audit Confirming Its FY 2023 Cash Balance and the High Integrity of Its Systems and Controls and Refutes Muddy Waters’ Allegations Regarding Transactions That Occurred Between 10 and 25 Years Ago | 20102020 Medical Services | New |
| 22 Oct 2024 07:15 CEST |
EUROFINS SCIENTIFIC | Eurofins Confirms Profitability and Cash Flow Objectives for 2024 Leading to Higher Profit Margins in Spite of the Impact of the Post-COVID Reset of BioPharma Pipelines | 20102020 Medical Services | Sales |
| 22 Oct 2024 07:00 CEST |
Tomra Systems ASA | TOMRA: 3Q 2024: 15% increase in EBITA adj. with strong quarter in Collection, good progress on the improvement program in Food, and stable development in Recycling | 50204000 Machinery: Industrial | Half yearly financial reports and audit reports/limited reviews |
| 22 Oct 2024 07:00 CEST |
VÅR ENERGI ASA | Vår Energi reports strong financial results in the third quarter 2024 | 60101015 Offshore Drilling and Other Services | Half yearly financial reports and audit reports/limited reviews |
| 22 Oct 2024 07:00 CEST |
VÅR ENERGI ASA | Key information relating to cash dividend to be paid by Vår Energi ASA | 60101015 Offshore Drilling and Other Services | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Oct 2024 07:00 CEST |
VÅR ENERGI ASA | Vår Energi unlocking high-value barrels in the Balder area | 60101015 Offshore Drilling and Other Services | Non-regulatory press releases |
| 22 Oct 2024 07:00 CEST |
Gjensidige Forsikring ASA | Høyere forsikringsresultat drevet av inntektsvekst | 30302010 Full Line Insurance | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
| 22 Oct 2024 07:00 CEST |
Gjensidige Forsikring ASA | Higher insurance service result driven by revenue growth | 30302010 Full Line Insurance | Half yearly financial reports and audit reports/limited reviews |
| 22 Oct 2024 07:00 CEST |
INTERPARFUMS | Q3 2024 sales: €258m (+20%) | 40204035 Cosmetics | Share history |
| 22 Oct 2024 07:00 CEST |
INTERPARFUMS | Chiffre d\'affaires 3ème trimestre 2024 : 258 M€ (+20 %) | 40204035 Cosmetics | Share history |
| 22 Oct 2024 07:00 CEST |
GIGANTE SALMON AS | Gigante Salmon AS: Publisering av kvartalsrapport Q3 | 45102010 Farming, Fishing, Ranching and Plantations | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
| 22 Oct 2024 07:00 CEST |
GIGANTE SALMON AS | Gigante Salmon AS: Publication of Q3 Report | 45102010 Farming, Fishing, Ranching and Plantations | Half yearly financial reports and audit reports/limited reviews |
| 21 Oct 2024 21:41 CEST |
ATLANTIC SAPPHIRE | Atlantic Sapphire ASA: New share capital registered | 45102010 Farming, Fishing, Ranching and Plantations | Total number of voting rights and capital |
| 21 Oct 2024 21:30 CEST |
NORDEA BANK | Nordea Bank Abp: Repurchase of own shares on 21.10.2024 | 30101010 Banks | Acquisition or disposal of the issuer’s own shares |
| 21 Oct 2024 21:30 CEST |
AEGA | Aega ASA - Mandatory notification of sale of shares by close associate to primary insider | 30202000 Diversified Financial Services | Mandatory notification of trade primary insiders |
| 21 Oct 2024 21:30 CEST |
AEGA | AEGA ASA - Mandatory notification of sale of shares by primary insider | 30202000 Diversified Financial Services | Mandatory notification of trade primary insiders |
| 21 Oct 2024 21:23 CEST |
FACEPHI | Interim Financial Information 30-6-2024 and Results Report | 10101015 Software | Commercial results |
| 21 Oct 2024 21:17 CEST |
Schibsted ASA | Schibsted ASA (SCHA/SCHB) - Repurchase of own shares | 10101020 Consumer Digital Services | Acquisition or disposal of the issuer’s own shares |
| 21 Oct 2024 21:01 CEST |
GREENVOLT ENERGIAS RENOVAVEIS S.A. | Greenvolt - Energias Renováveis, S.A. announces qualifying holdings | 65101010 Alternative Electricity | Change in Capital |
| 21 Oct 2024 21:00 CEST |
GREENVOLT ENERGIAS RENOVAVEIS S.A. | Greenvolt - Energias Renováveis, S.A. informa sobre participação qualificada | 65101010 Alternative Electricity | Change in Capital |
| 21 Oct 2024 20:58 CEST |
GREENVOLT ENERGIAS RENOVAVEIS S.A. | Greenvolt - Energias Renováveis, S.A. announces qualifying holdings | 65101010 Alternative Electricity | Change in Capital |
| 21 Oct 2024 20:58 CEST |
GREENVOLT ENERGIAS RENOVAVEIS S.A. | Greenvolt - Energias Renováveis, S.A. informa sobre participação qualificada | 65101010 Alternative Electricity | Change in Capital |
| 21 Oct 2024 20:00 CEST |
ABIONYX PHARMA | ABIONYX Pharma reçoit un avis positif de l'EMA pour le CER-001 dans la Déficience en LCAT | 20103010 Biotechnology | Other subject |
| 21 Oct 2024 20:00 CEST |
ABIONYX PHARMA | ABIONYX Pharma Received Positive Feedback from the EMA for CER-001 in LCAT Deficiency | 20103010 Biotechnology | Other subject |